These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 26868826)
1. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. Tenekecioglu E; Farooq V; Bourantas CV; Silva RC; Onuma Y; Yılmaz M; Serruys PW BMC Cardiovasc Disord; 2016 Feb; 16():38. PubMed ID: 26868826 [TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention: balloons, stents and scaffolds. Colleran R; Kastrati A Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189 [TBL] [Abstract][Full Text] [Related]
3. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. Wiebe J; Nef HM; Hamm CW J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240 [TBL] [Abstract][Full Text] [Related]
4. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds. Ielasi A; Tespili M Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477 [TBL] [Abstract][Full Text] [Related]
5. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932 [TBL] [Abstract][Full Text] [Related]
6. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies]. Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812 [TBL] [Abstract][Full Text] [Related]
7. Vascular Intervention: From Angioplasty to Bioresorbable Vascular Scaffold. Du F; Zhou J Adv Exp Med Biol; 2018; 1097():181-189. PubMed ID: 30315545 [TBL] [Abstract][Full Text] [Related]
8. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Cassese S; Byrne RA; Ndrepepa G; Kufner S; Wiebe J; Repp J; Schunkert H; Fusaro M; Kimura T; Kastrati A Lancet; 2016 Feb; 387(10018):537-544. PubMed ID: 26597771 [TBL] [Abstract][Full Text] [Related]
9. Bioresorbable vascular scaffold in patients with complex coronary artery disease. Tamburino CI; Capranzano P; Longo G; Immè S; Tamburino G; Scalia M; Condorelli A; Francaviglia B; LA Manna A; Sgroi C; Grasso C; DI Salvo ME; Capodanno D; Tamburino C Minerva Cardioangiol; 2016 Aug; 64(4):481-6. PubMed ID: 27128353 [TBL] [Abstract][Full Text] [Related]
18. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease. Dziewierz A; Dudek D Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247 [TBL] [Abstract][Full Text] [Related]
20. A review of bioresorbable scaffolds: hype or hope? Tan HC; Ananthakrishna R Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]